4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Ostial vs. wide area circumferential ablation guided by the Ablation Index in paroxysmal atrial fibrillation

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Aims

          Pulmonary vein isolation (PVI) guided by the Ablation Index (AI) has shown high acute and mid-term efficacy in the treatment of paroxysmal atrial fibrillation (AF). Previous data before the AI-era had suggested that wide-area circumferential ablation (WACA) was preferable to ostial ablation. However, with the use of AI, we hypothesize that ostial circumferential ablation is non-inferior to WACA and can improve outcomes in paroxysmal AF.

          Methods and results

          Prospective, multicentre, non-randomized, non-inferiority study of consecutive patients were referred for paroxysmal AF ablation from January 2020 to September 2021. All procedures were performed using the AI software, and patients were separated into two different groups: WACA vs. ostial circumferential ablation. Acute reconnection, procedural data, and 1-year arrhythmia recurrence were assessed. During the enrolment period, 162 patients (64% males, mean age of 60 ± 11 years) fulfilled the study inclusion criteria—81 patients [304 pulmonary vein (PV)] in the WACA group and 81 patients (301 PV) in the ostial group. Acute PV reconnection was identified in 7.9% [95% confidence interval (CI), 4.9–11.1%] of PVs in the WACA group compared with 3.3% (95% CI, 1.8–6.1%) of PVs in the ostial group [ P < 0.001 for non-inferiority; adjusted odds ratio 0.51 (95% CI, 0.23–0.83), P = 0.05]. Patients in the WACA group had longer ablation (35 vs. 29 min, P = 0.001) and procedure (121 vs. 102 min, P < 0.001) times. No significant difference in arrhythmia recurrence was seen at 1-year of follow-up [11.1% in WACA vs. 9.9% in ostial, hazard ratio 1.13 (95% CI, 0.44–1.94), P = 0.80 for superiority].

          Conclusion

          In paroxysmal AF patients treated with tailored AI-guided PVI, ostial circumferential ablation is not inferior to WACA with regard to acute PV reconnection, while allowing quicker procedures with less ablation time.

          Graphical Abstract

          Graphical Abstract

          Distribution of acute pulmonary vein reconnection in both groups [wide-area circumferential ablation (WACA) vs. ostial] (central panel), with an illustration of the typical location for ablation lines in each corresponding group, in a posterior view (left panel). Ostial ablation was not inferior to WACA with regard to acute pulmonary vein reconnections ( P < 0.001 for non-inferiority; P = 0.05 adjusted for superiority) and arrhythmia recurrence at 1-year of follow-up ( P < 0.001 for non-inferiority; P = 0.80 for superiority), while requiring less ablation ( P = 0.001) and allowing for quicker procedures ( P < 0.001) (right panel).

          Related collections

          Most cited references32

          • Record: found
          • Abstract: not found
          • Article: not found

          OUP accepted manuscript

          (2020)
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients.

            Summary. A variety of definitions of major bleeding have been used in published clinical studies, and this diversity adds to the difficulty in comparing data between trials and in performing meta-analyses. In the first step towards unified definitions of bleeding complications, the definition of major bleeding in non-surgical patients was discussed at the Control of Anticoagulation Subcommittee of the International Society on Thrombosis and Haemostasis. Arising from that discussion, a definition was developed that should be applicable to studies with all agents that interfere with hemostasis, including anticoagulants, platelet function inhibitors and fibrinolytic drugs. The definition and the text that follows have been reviewed and approved by the cochairs of the subcommittee and the revised version is published here. The intention is to also seek approval of this definition from the regulatory authorities.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Cryoballoon or Radiofrequency Ablation for Paroxysmal Atrial Fibrillation

              Current guidelines recommend pulmonary-vein isolation by means of catheter ablation as treatment for drug-refractory paroxysmal atrial fibrillation. Radiofrequency ablation is the most common method, and cryoballoon ablation is the second most frequently used technology.
                Bookmark

                Author and article information

                Contributors
                Journal
                Europace
                Europace
                europace
                Europace
                Oxford University Press (US )
                1099-5129
                1532-2092
                June 2023
                22 June 2023
                22 June 2023
                : 25
                : 6
                : euad160
                Affiliations
                Pacing and Electrophysiology Unit, Department of Cardiology, Coimbra’s Hospital and University Center , Morada: Praceta Prof Mota Pinto, Coimbra 3000-075, Portugal
                Department of Cardiology, Hospital da Luz Arrábida , V. N. Gaia, Portugal
                Pacing and Electrophysiology Unit, Department of Cardiology, Coimbra’s Hospital and University Center , Morada: Praceta Prof Mota Pinto, Coimbra 3000-075, Portugal
                Department of Cardiology, Clinique Saint Pierre , Perpignan, France
                Department of Cardiology, University Hospital Center of São João , Porto, Portugal
                Department of Cardiology, Vila Nova de Gaia and Espinho Hospital Center , V. N. Gaia, Portugal
                Department of Cardiology, Clinique Saint Pierre , Perpignan, France
                Department of Cardiology, University Hospital Center of São João , Porto, Portugal
                Department of Cardiology, Vila Nova de Gaia and Espinho Hospital Center , V. N. Gaia, Portugal
                Biosense Webster , Portugal
                Pacing and Electrophysiology Unit, Department of Cardiology, Coimbra’s Hospital and University Center , Morada: Praceta Prof Mota Pinto, Coimbra 3000-075, Portugal
                ICBR, Faculty of Medicine, University of Coimbra , Coimbra, Portugal
                Pacing and Electrophysiology Unit, Department of Cardiology, Coimbra’s Hospital and University Center , Morada: Praceta Prof Mota Pinto, Coimbra 3000-075, Portugal
                Pacing and Electrophysiology Unit, Department of Cardiology, Coimbra’s Hospital and University Center , Morada: Praceta Prof Mota Pinto, Coimbra 3000-075, Portugal
                ICBR, Faculty of Medicine, University of Coimbra , Coimbra, Portugal
                Author notes
                Corresponding author. Tel: +351 967734126. E-mail address: peter@ 123456chuc.min-saude.pt

                Conflict of interest: P.A.S. has received consulting fees from Biosense Webster, Boston Scientific, Medtronic, and Abbott. S.B. has received training grants from Biosense Webster and Biotronik. M.P. is an employee of Biosense Webster. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

                Author information
                https://orcid.org/0000-0002-9791-767X
                https://orcid.org/0000-0003-4064-3767
                https://orcid.org/0000-0002-3716-0257
                https://orcid.org/0009-0004-3852-3314
                https://orcid.org/0000-0001-9717-6202
                https://orcid.org/0009-0000-2650-0036
                https://orcid.org/0000-0001-7827-4042
                https://orcid.org/0000-0001-5790-9483
                https://orcid.org/0000-0001-9206-8026
                https://orcid.org/0000-0002-6173-3449
                https://orcid.org/0000-0001-7836-8161
                https://orcid.org/0000-0001-9255-3064
                Article
                euad160
                10.1093/europace/euad160
                10286571
                37345859
                11d58e77-b0a6-450a-b61c-84c4d6a245ff
                © The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License ( https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com

                History
                : 10 March 2023
                : 23 May 2023
                Page count
                Pages: 9
                Funding
                Funded by: Biosense Webster, doi 10.13039/100007497;
                Award ID: IIS-490
                Categories
                Clinical Research
                AcademicSubjects/MED00200
                Eurheartj/1
                Eurheartj/3

                Cardiovascular Medicine
                wide-area circumferential ablation,ostial circumferential,pulmonary vein isolation,paroxysmal atrial fibrillation,ablation index,acute reconnection

                Comments

                Comment on this article